1. Home
  2. ARMP vs BNC Comparison

ARMP vs BNC Comparison

Compare ARMP & BNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Armata Pharmaceuticals Inc.

ARMP

Armata Pharmaceuticals Inc.

N/A

Current Price

$8.06

Market Cap

295.5M

Sector

Health Care

ML Signal

N/A

Logo CEA Industries Inc.

BNC

CEA Industries Inc.

N/A

Current Price

$2.73

Market Cap

287.3M

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
ARMP
BNC
Founded
N/A
N/A
Country
United States
United States
Employees
61
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Industrial Machinery/Components
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
295.5M
287.3M
IPO Year
1996
N/A

Fundamental Metrics

Financial Performance
Metric
ARMP
BNC
Price
$8.06
$2.73
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$15.00
N/A
AVG Volume (30 Days)
73.3K
219.4K
Earning Date
05-07-2026
07-24-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$0.22
Revenue Growth
N/A
N/A
52 Week Low
$1.74
$2.39
52 Week High
$14.98
$31.62

Technical Indicators

Market Signals
Indicator
ARMP
BNC
Relative Strength Index (RSI) 37.57 38.48
Support Level $7.43 $2.68
Resistance Level $12.11 $3.05
Average True Range (ATR) 1.12 0.22
MACD -0.22 -0.03
Stochastic Oscillator 14.20 2.78

Price Performance

Historical Comparison
ARMP
BNC

About ARMP Armata Pharmaceuticals Inc.

Armata Pharmaceuticals Inc is a late clinical-stage biotechnology company focused on the development of high-purity and potent, pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using proprietary bacteriophage-based technology. It has completed three Phase 2 clinical trials to date. The Company operates and manages its business as one reportable operating segment, which is the business of developing pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat acute and chronic bacterial infections using its proprietary bacteriophage-based technology.

About BNC CEA Industries Inc.

CEA Industries Inc through its subsidiary is focused on selling environmental control and other technologies and services to the Controlled Environment Agriculture ("CEA") industry. The company provides integrated mechanical, electrical, and plumbing ("MEP") engineering design, proprietary and curated environmental control equipment, and automation offerings that serve the CEA industry. The Company has one operating segment that is dedicated to the manufacture and sale of its products.

Share on Social Networks: